Edition:
United Kingdom

Kazia Therapeutics Ltd (KZIA.OQ)

KZIA.OQ on NASDAQ Stock Exchange Capital Market

3.15USD
12 Oct 2018
Change (% chg)

-- (--)
Prev Close
$3.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,629
52-wk High
$6.64
52-wk Low
$2.28

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.05 -0.134
Dec 0.07 0.009
FY 2017 Jun '17 0.11 -0.134
Dec 0.14 -0.092
FY 2016 Jun '16 0.24 -0.192
Dec 0.17 -0.090
 
*Note: Units in Millions ofAustralian Dollars
**Note: Units in Australian Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Jun-18 1 4.06 4.06 4.06 7.35
Year Ending Jun-19 1 14.64 14.64 14.64 17.31
Earnings (per share)
Year Ending Jun-18 1 -310.89 -310.89 -310.89 -351.27
Year Ending Jun-19 1 -177.48 -177.48 -177.48 -219.23
Sales and Profit Figures in Australian Dollar (AUD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 86.20 32.69
P/E High - Last 5 Yrs. -- 290.01 45.21
P/E Low - Last 5 Yrs. -- 90.56 23.82
Beta -0.08 0.93 0.88
Price to Sales (TTM) 79.63 123.88 5.82
Price to Book (MRQ) 0.18 15.34 4.90
Price to Tangible Book (MRQ) 2.10 14.54 6.53
Price to Cash Flow (TTM) -- 70.75 22.98
% Owned Institutions 1.59 13.94 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.34 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.56 5.38
Payout Ratio(TTM) -- 16.91 43.96

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -55.57 391.55 7.73
Sales (TTM) vs TTM 1 Yr. Ago -38.66 73.89 5.32
Sales - 5 Yr. Growth Rate -29.68 30.83 9.89
EPS (MRQ) vs Qtr. 1 Yr. Ago 82.47 24.83 22.57
EPS (TTM) vs TTM 1 Yr. Ago 55.28 -- --
EPS - 5 Yr. Growth Rate -- 37.95 10.95
Capital Spending - 5 Yr. Growth Rate 63.40 38.70 14.94

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.94 2.25
Current Ratio (MRQ) 3.62 5.32 3.05
LT Debt to Equity (MRQ) 0.00 35.04 12.63
Total Debt to Equity (MRQ) 0.00 36.85 16.96
Interest Coverage (TTM) -381,217.00 -97.99 37.54

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.92
Gross Margin - 5 Yr. Avg. -- 49.23 52.45
EBITD Margin (TTM) -6,924.99 -- --
EBITD - 5 Yr. Avg -2,506.94 -574.53 11.10
Operating Margin (TTM) -7,495.51 -770.03 4.36
Operating Margin - 5 Yr. Avg. -2,718.78 -594.78 6.45
Pre-Tax Margin (TTM) -4,367.83 -731.81 5.41
Pre-Tax Margin - 5 Yr. Avg. -2,028.72 -600.11 6.89
Net Profit Margin (TTM) -4,288.05 -732.73 1.68
Net Profit Margin - 5 Yr. Avg. -2,018.50 -603.07 3.14
Effective Tax Rate (TTM) -- 23.70 23.23
Effective Tax Rate - 5 Yr. Avg. -- 18.84 24.11

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,887,281 812,879,200
Net Income/Employee (TTM) -- 1,727,321 95,609,515
Receivable Turnover (TTM) 0.11 19.88 5.78
Inventory Turnover (TTM) -- 2.39 3.60
Asset Turnover (TTM) 0.01 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -29.88 -0.96 10.94
Return on Assets - 5 Yr. Avg. -34.24 3.30 12.05
Return on Investment (TTM) -33.03 0.73 14.32
Return on Investment - 5 Yr. Avg. -38.70 2.37 15.66
Return on Equity (TTM) -36.01 1.82 16.04
Return on Equity - 5 Yr. Avg. -39.42 3.23 16.92
  1 Year 3 Year 5 Year
Sales % -38.66 42.12 -29.68
EPS (TTM) % 79.79 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kazia Therapeutics Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 2.22%
# of Holders: 8
Total Shares Held: 107,398
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.